Nintedanib Capsules, 100 mg and 150 mg
NDC 76282-786, Nintedanib, capsule, from EXELAN PHARMACEUTICALS INC..
- Product NDC
- 76282-786
- Status
- Listed
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212609
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-786 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NINTEDANIB ESYLATE100 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-786-60 | 76282078660 | 60 CAPSULE in 1 BOTTLE (76282-786-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/60d8104e-cb6c-4f4f-8159-95ed57346ffa
Use it
Look up 76282-786 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-786 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-786. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.